Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Immunovant Inc (NASDAQ: IMVT) closed at $18.79 down -6.14% from its previous closing price of $20.02. In other words, the price has decreased by -$6.14 from its previous closing price. On the day, 0.81 million shares were traded. IMVT stock price reached its highest trading level at $19.89 during the session, while it also had its lowest trading level at $18.77.
Ratios:
For a deeper understanding of Immunovant Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 03, 2025, initiated with a Hold rating and assigned the stock a target price of $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 07 ’25 when Fromkin Andrew J. sold 8,000 shares for $19.60 per share. The transaction valued at 156,769 led to the insider holds 91,913 shares of the business.
ANDREW J FROMKIN bought 8,000 shares of IMVT for $156,160 on Mar 07 ’25. On Feb 19 ’25, another insider, Macias William L., who serves as the Chief Medical Officer of the company, sold 2,055 shares for $20.86 each. As a result, the insider received 42,867 and left with 357,353 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 3191688192 and an Enterprise Value of 2817020160.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.74, which has changed by -0.40481472 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $35.97, while it has fallen to a 52-week low of $17.65. The 50-Day Moving Average of the stock is -11.53%, while the 200-Day Moving Average is calculated to be -29.60%.
Shares Statistics:
For the past three months, IMVT has traded an average of 1.23M shares per day and 1045400 over the past ten days. A total of 147.20M shares are outstanding, with a floating share count of 69.37M. Insiders hold about 59.16% of the company’s shares, while institutions hold 47.38% stake in the company. Shares short for IMVT as of 1740700800 were 15390952 with a Short Ratio of 12.53, compared to 1738281600 on 13149997. Therefore, it implies a Short% of Shares Outstanding of 15390952 and a Short% of Float of 17.59.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
